BILTRICIDE

This brand name is authorized in Australia, Canada, Estonia, France, Hong Kong, Japan, Netherlands, New Zealand, United States, South Africa

Active ingredients

The drug BILTRICIDE contains one active pharmaceutical ingredient (API):

1 Praziquantel UNII 6490C9U457 - PRAZIQUANTEL

Praziquantel induces a rapid contraction of schistosomes by a specific effect on the permeability of the cell membrane. The medicine further causes vacuolisation and disintegration of the schistosome tegument. Read about Praziquantel

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BILTRICIDE Film-coated tablet	Medicines and Medical Devices Safety Authority (NZ)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P02BA01	Praziquantel	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02B Antitrematodals → P02BA Quinoline derivatives and related substances
Discover more medicines within P02BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 9447F
Country: CA	Health Products and Food Branch	Identifier(s): 02230897
Country: EE	Ravimiamet	Identifier(s): 1187894, 1195714, 1346060, 1346509
Country: FR	Base de données publique des médicaments	Identifier(s): 60996403
Country: HK	Department of Health Drug Office	Identifier(s): 25428
Country: JP	医薬品医療機器総合機構	Identifier(s): 6429006F1039
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 23604
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15071
Country: US	FDA, National Drug Code	Identifier(s): 50419-747
Country: ZA	Health Products Regulatory Authority	Identifier(s): P/12/23